| 摘要 |
Composition (A) suitable for topical application or oral administration, comprises at least one 3beta-hydroxysteroid dehydrogenase inhibitor (I) to treat or prevent signs of cutaneous aging, is new. Independent claims are also included for: (1) a method of achieving cellular renewal and/or improving the density of the fibrous macromolecules of the dermis, comprising topically applying or orally administering composition (A); (2) a method of regulating the synthesis and/or degradation of the matrix proteins of the dermis, comprising topically applying or orally administering composition (A); (3) a method of treating the slackening of the cutaneous and subcutaneous tissues, comprising topically applying or orally administering composition (A); (4) a method for brightening the lustre of the skin and/or reducing wrinkles and lines of the skin, comprising topically applying or orally administering composition (A); and (5) a method for regulating the pigmentation processes of the skin and exoskeleton and/or the seborrhea and/or the growth of hair and/or body hair and/or nails, comprising topically applying or orally administering composition (A). |
